MedPath

Gutmovin

Brand Name: Gutmovin

Generic Name: Mosapride Citrate

Active
Registration Number

DRP-6554

Dosage Form

Film-Coated Tablet

Issuance Date

April 1, 2025

Expiry Date

March 4, 2038

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 100's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Gastroprokinetic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Mosapride CitrateActive
Monograph: Mosapride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform